<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">52687</article-id><article-id pub-id-type="doi">10.7554/eLife.52687</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Squalene-based adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-161361"><name><surname>Kim</surname><given-names>Eui Ho</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161681"><name><surname>Woodruff</surname><given-names>Matthew C</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-185070"><name><surname>Grigoryan</surname><given-names>Lilit</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161682"><name><surname>Maier</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161684"><name><surname>Lee</surname><given-names>Song Hee</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-184036"><name><surname>Mandal</surname><given-names>Pratushya</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161683"><name><surname>Cortese</surname><given-names>Mario</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161685"><name><surname>Natrajan</surname><given-names>Muktha S</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161686"><name><surname>Ravindran</surname><given-names>Rajesh</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161687"><name><surname>Ma</surname><given-names>Huailiang</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-6034"><name><surname>Merad</surname><given-names>Miriam</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-184037"><name><surname>Gitlin</surname><given-names>Alexander D</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-2536"><name><surname>Mocarski</surname><given-names>Edward S</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-161689"><name><surname>Jacob</surname><given-names>Joshy</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-128308"><name><surname>Pulendran</surname><given-names>Bali</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6517-4333</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Emory Vaccine Center</institution>, <institution>Emory University</institution>, <addr-line><named-content content-type="city">Atlanta</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Medicine</institution>, <institution>Emory University</institution>, <addr-line><named-content content-type="city">Atlanta</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">ITI</institution>, <institution>Stanford University</institution>, <addr-line><named-content content-type="city">Stanford</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Tisch Cancer Institute</institution>, <institution>Icahn School of Medicine at Mount Sinai</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">EVC</institution>, <institution>Emory University</institution>, <addr-line><named-content content-type="city">Atlanta</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Microbiology and Immunology</institution>, <institution>Emory University</institution>, <addr-line><named-content content-type="city">Atlanta</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">ITI</institution>, <institution>Stanford University</institution>, <addr-line><named-content content-type="city">Palo Alto</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution content-type="dept">Hope Clinic</institution>, <institution>Emory University</institution>, <addr-line><named-content content-type="city">Atlanta</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution content-type="dept">Yerkes</institution>, <institution>Emory University</institution>, <addr-line><named-content content-type="city">Atlanta</named-content></addr-line>, <country>United States</country></aff><aff id="aff10"><institution content-type="dept">Precision Immunology Institute</institution>, <institution>Icahn School of Medicine at Mount Sinai</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff><aff id="aff11"><institution content-type="dept">Physiological Chemistry</institution>, <institution>Genentech</institution>, <addr-line><named-content content-type="city">San Francisco</named-content></addr-line>, <country>United States</country></aff><aff id="aff12"><institution content-type="dept">Department of Microbiology and Immunology</institution>, <institution>Emory University</institution>, <addr-line><named-content content-type="city">Atlanta</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-62461"><name><surname>Schoggins</surname><given-names>John W</given-names></name><role>Reviewing editor</role><aff><institution>University of Texas Southwestern Medical Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>bpulend@stanford.edu</email> (BP);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>09</day><month>06</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e52687</elocation-id><history><date date-type="received"><day>12</day><month>10</month><year>2019</year></date><date date-type="accepted"><day>08</day><month>06</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Kim et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Kim et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-52687-v1.pdf"/><abstract><p>The squalene-based oil-in-water emulsion (SE) vaccine adjuvant MF59 has been administered to more than 100 million people in more than 30 countries, in both seasonal and pandemic influenza vaccines. Despite its wide use and efficacy, its mechanisms of action remains unclear. In this study we demonstrate that immunization of mice with MF59 or its mimetic AddaVax (AV) plus soluble antigen results in robust antigen-specific antibody and CD8 T cell responses in lymph nodes and non-lymphoid tissues. Immunization triggered rapid RIPK3-kinase dependent necroptosis in the lymph node which peaked at 6 hours, followed by a sequential wave of apoptosis. Immunization with alum plus antigen did not induce RIPK3 kinase-dependent signaling. RIPK3-dependent signaling induced by MF59 or AV was essential for cross-presentation of antigen to CD8<sup> </sup>T cells by Batf3-dependent CD8<sup>+</sup> DCs. Consistent with this, RIPK3-kinase deficient or Batf3 deficient mice were impaired in their ability to mount adjuvant-enhanced CD8<sup> </sup>T cell responses. However, CD8 T cell responses were unaffected in mice deficient in MLKL, a downstream mediator of necroptosis. Surprisingly, antibody responses were unaffected in RIPK3-kinase or Batf3 deficient mice. In contrast, antibody responses were impaired by in vivo administration of the pan-caspase inhibitor Z-VAD-FMK, but normal in caspase-1 deficient mice, suggesting a contribution from apoptotic caspases, in the induction of antibody responses. These results demonstrate that squalene-based vaccine adjuvants induce antigen-specific CD8 T cell and antibody responses, through RIPK3-dependent and-independent pathways, respectively.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R37 DK057665</award-id><principal-award-recipient><name><surname>Pulendran</surname><given-names>Bali</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R37 AI048638</award-id><principal-award-recipient><name><surname>Pulendran</surname><given-names>Bali</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>U19 AI057266</award-id><principal-award-recipient><name><surname>Pulendran</surname><given-names>Bali</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#2002593) of Emory University.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><supplementary-material><ext-link xlink:href="elife-52687-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>